Vaccination Types and Their Mechanisms

Different Vaccine Types

  • Various vectors can be used to initiate immunity, including:
    • Synthetic peptides (pieces of proteins)
    • Whole inactivated viruses
    • Live attenuated viruses (mutated to be non-infectious)
    • DNA vaccines

Live Attenuated Vaccines

  • Definition: Contain live pathogens that are modified to be non-infectious.
  • Pros:
    • Produces the most robust immune response similar to natural infection.
    • Usually does not require booster shots.
  • Cons:
    • Small chance of reversion to pathogenic form.
    • Can have serious side effects.
    • Requires cold chain storage, making it more expensive to transport.

Inactivated Vaccines

  • Types: Can be classified into whole agent and subunit vaccines.
    • Whole Agent: Entire pathogen is administered, killed by heat or chemicals.
    • Subunit: Uses only a part of the microbe, typically antigenic fragments.
  • Pros:
    • Safer; no risk of reversion to pathogenic state.
    • Stimulates B cell response.
  • Common Examples: Flu (A strain), polio, rabies (can be given post-exposure).
  • Cons:
    • Weaker immune response; requires booster shots (e.g., flu annually).
    • Possible denaturation of proteins during inactivation can affect efficacy.

Toxoid Vaccines

  • Definition: Vaccines made from toxins produced by pathogens, modified to be non-toxic (toxoids).
  • Common Uses: Vaccinations against diseases such as tetanus and diphtheria.
  • Pros:
    • Similar to subunit vaccines, promotes immune response without introducing toxicity.
  • Cons:
    • Immune response may not be as strong; booster shots needed every 10 years.

mRNA Vaccines

  • Mechanism: Utilizes the central dogma (DNA → RNA → Protein) to induce immunity.
    • Isolates mRNA that codes for viral proteins (e.g., the spike protein in SARS-CoV-2).
  • Pros:
    • Activates both B and T cell response, promoting strong long-term immunity.
    • Specific and easier to manufacture; poses no risk of reverting to pathogenic form.
  • Delivery: Lipid nanoparticles facilitate entry into host cells, allowing for translation of proteins.
  • Common Examples: Pfizer and Moderna COVID-19 vaccines.
  • Cons:
    • mRNA is unstable; requires low-temperature storage, complicating distribution and production.
    • Potential for mild side effects indicating a robust immune response (e.g., fever, fatigue).